Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1994 Aug;145(2):268–275.

CD5 expression in thymic carcinoma.

T Hishima 1, M Fukayama 1, M Fujisawa 1, Y Hayashi 1, K Arai 1, N Funata 1, M Koike 1
PMCID: PMC1887382  PMID: 7519823

Abstract

To determine the differences between the cellular characteristics of thymic carcinoma and thymoma, immunohistochemical analysis with lymphocyte markers (CD1a, 3, 4, 5, 8, 10, 20, 21, 25, 30, 57, and 72) was performed on 23 thymic epithelial tumors other than lymphocytic thymoma: overt thymic carcinoma (OC, n = 7), atypical thymoma (n = 5), and typical thymoma (epithelial or mixed thymoma, n = 11). Among the surface antigens examined, CD5, a type of receptor molecule that signals cell growth in T cells, was expressed in neoplastic epithelial cells of the thymus, in OC (seven of seven) and atypical thymoma (two of five), but not in typical thymoma. Double labeling immunofluorescence demonstrated expression of CD5 in cytokeratin-positive cells. The CD5 molecule extracted from an OC tumor showed the same molecular size as that in the spleen, but CD72, a ligand of CD5 on the surface of B cells, was not found in the epithelial cells of OC or atypical thymoma. Expression of CD5 was not observed in carcinomas of other organs, such as lung (n = 15), breast (n = 4), esophagus (n = 6), stomach (n = 6), colon (n = 9), and uterine cervix (n = 3). CD5 is closely related to morphological changes in thymic epithelial tumors and may play a role in the evolution of OC through receptor-ligand interaction.

Full text

PDF
268

Images in this article

270Figure 1
on p.270
272Figure 2
on p.272
273Figure 3
on p.273

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asamura H., Nakajima T., Mukai K., Noguchi M., Shimosato Y. Degree of malignancy of thymic epithelial tumors in terms of nuclear DNA content and nuclear area. An analysis of 39 cases. Am J Pathol. 1988 Dec;133(3):615–622. [PMC free article] [PubMed] [Google Scholar]
  2. Fukayama M., Maeda Y., Funata N., Koike M., Saito K., Sakai T., Ikeda T. Pulmonary and pleural thymoma. Diagnostic application of lymphocyte markers to the thymoma of unusual site. Am J Clin Pathol. 1988 May;89(5):617–621. doi: 10.1093/ajcp/89.5.617. [DOI] [PubMed] [Google Scholar]
  3. Grogan T. M., Verdi C. The expression of common acute lymphoblastic leukemia antigen by bile canaliculi. N Engl J Med. 1985 Apr 11;312(15):993–994. doi: 10.1056/NEJM198504113121517. [DOI] [PubMed] [Google Scholar]
  4. Kirchner T., Schalke B., Buchwald J., Ritter M., Marx A., Müller-Hermelink H. K. Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol. 1992 Dec;16(12):1153–1169. [PubMed] [Google Scholar]
  5. Kodama T., Watanabe S., Sato Y., Shimosato Y., Miyazawa N. An immunohistochemical study of thymic epithelial tumors. I. Epithelial component. Am J Surg Pathol. 1986 Jan;10(1):26–33. doi: 10.1097/00000478-198601000-00004. [DOI] [PubMed] [Google Scholar]
  6. Kuo T. T., Chang J. P., Lin F. J., Wu W. C., Chang C. H. Thymic carcinomas: histopathological varieties and immunohistochemical study. Am J Surg Pathol. 1990 Jan;14(1):24–34. [PubMed] [Google Scholar]
  7. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  8. Luo W., Van de Velde H., von Hoegen I., Parnes J. R., Thielemans K. Ly-1 (CD5), a membrane glycoprotein of mouse T lymphocytes and a subset of B cells, is a natural ligand of the B cell surface protein Lyb-2 (CD72). J Immunol. 1992 Mar 15;148(6):1630–1634. [PubMed] [Google Scholar]
  9. Mahendran R., McIlhinney R., O'Hare M., Monaghan P., Gusterson B. Expression of the common acute lymphoblastic leukaemia antigen (CALLA) in the human breast. Mol Cell Probes. 1989 Mar;3(1):39–44. doi: 10.1016/0890-8508(89)90035-2. [DOI] [PubMed] [Google Scholar]
  10. Masaoka A., Monden Y., Nakahara K., Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981 Dec 1;48(11):2485–2492. doi: 10.1002/1097-0142(19811201)48:11<2485::aid-cncr2820481123>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  11. Metzgar R. S., Borowitz M. J., Jones N. H., Dowell B. L. Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues. J Exp Med. 1981 Oct 1;154(4):1249–1254. doi: 10.1084/jem.154.4.1249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Morinaga S., Sato Y., Shimosato Y., Sinkai T., Tsuchiya R. Multiple thymic squamous cell carcinomas associated with mixed type thymoma. Am J Surg Pathol. 1987 Dec;11(12):982–988. doi: 10.1097/00000478-198712000-00009. [DOI] [PubMed] [Google Scholar]
  13. Pescarmona E., Rosati S., Rendina E. A., Venuta F., Baroni C. D. Well-differentiated thymic carcinoma: a clinico-pathological study. Virchows Arch A Pathol Anat Histopathol. 1992;420(2):179–183. doi: 10.1007/BF02358810. [DOI] [PubMed] [Google Scholar]
  14. Sato Y., Watanabe S., Mukai K., Kodama T., Upton M. P., Goto M., Shimosato Y. An immunohistochemical study of thymic epithelial tumors. II. Lymphoid component. Am J Surg Pathol. 1986 Dec;10(12):862–870. doi: 10.1097/00000478-198612000-00005. [DOI] [PubMed] [Google Scholar]
  15. Shimosato Y., Kameya T., Nagai K., Suemasu K. Squamous cell carcinoma of the thymus. An analysis of eight cases. Am J Surg Pathol. 1977 Jun;1(2):109–121. doi: 10.1097/00000478-197706000-00002. [DOI] [PubMed] [Google Scholar]
  16. Snover D. C., Levine G. D., Rosai J. Thymic carcinoma. Five distinctive histological variants. Am J Surg Pathol. 1982 Jul;6(5):451–470. [PubMed] [Google Scholar]
  17. Spertini F., Stohl W., Ramesh N., Moody C., Geha R. S. Induction of human T cell proliferation by a monoclonal antibody to CD5. J Immunol. 1991 Jan 1;146(1):47–52. [PubMed] [Google Scholar]
  18. Suster S., Rosai J. Histology of the normal thymus. Am J Surg Pathol. 1990 Mar;14(3):284–303. doi: 10.1097/00000478-199003000-00010. [DOI] [PubMed] [Google Scholar]
  19. Suster S., Rosai J. Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer. 1991 Feb 15;67(4):1025–1032. doi: 10.1002/1097-0142(19910215)67:4<1025::aid-cncr2820670427>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  20. Truong L. D., Mody D. R., Cagle P. T., Jackson-York G. L., Schwartz M. R., Wheeler T. M. Thymic carcinoma. A clinicopathologic study of 13 cases. Am J Surg Pathol. 1990 Feb;14(2):151–166. doi: 10.1097/00000478-199002000-00007. [DOI] [PubMed] [Google Scholar]
  21. Van de Velde H., von Hoegen I., Luo W., Parnes J. R., Thielemans K. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature. 1991 Jun 20;351(6328):662–665. doi: 10.1038/351662a0. [DOI] [PubMed] [Google Scholar]
  22. Wessel D., Flügge U. I. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem. 1984 Apr;138(1):141–143. doi: 10.1016/0003-2697(84)90782-6. [DOI] [PubMed] [Google Scholar]
  23. Wick M. R., Scheithauer B. W., Weiland L. H., Bernatz P. E. Primary thymic carcinomas. Am J Surg Pathol. 1982 Oct;6(7):613–630. doi: 10.1097/00000478-198210000-00003. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES